Sessions

PDF version
Wed 23 Oct

11:50

Advances in drug treatment

to
Auditorium II
Oral presentation session

Innovative health approaches

to
Auditorium III
Oral presentation session

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

14:20

Alcohol use in the young

to
Auditorium II
Oral presentation session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Tobacco, mental health and other substance use

to
Auditorium VII
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Substance use interventions in youth

to
Room 5A
Oral presentation session

Neurocognitive processes in behavioural addictions

to
Room 5B
Oral presentation session

Learning from Africa: workforce development, enhancement and support

to
Room 5C
Oral presentation session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

16:00

Alcohol use from brief intervention to harm reduction

to
Auditorium II
Oral presentation session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

The growing threat of synthetic drugs – developments and responses in North America and Europe

to
Auditorium VIII
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Assessment of behavioural addictions

to
Room 5B
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

17:50

Strengthening quality in substance use disorders treatment

to
Auditorium II
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session
Thu 24 Oct

11:50

Predicting the future: biomarkers for progression of alcohol use disorder

to
Auditorium II
Oral presentation session

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

14:20

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Conceptual frameworks for studying drug policy

to
Auditorium VI
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Nitazene-related fatal and non-fatal toxicity in Europe: hospital emergency perspective

to
Auditorium VIII
Oral presentation session

Public health and safety impacts of cannabis legalization in Canada: five years in review

to
Auditorium IV
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

Alcohol epidemiology: social inequalities

to
Auditorium II
Oral presentation session

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Policy issues in gambling

to
Room 5B
Oral presentation session

A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital

to
Room 5C
Oral presentation session

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

17:50

Alcohol and gender issues

to
Auditorium II
Oral presentation session

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Alcohol use among the elderly

to
Auditorium VI
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

New Research on Alcohol and Tobacco Policy

to
Room 5A
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder

to
Room 1.08
Oral presentation session
Fri 25 Oct

11:50

Alcohol: interventions and up-to-date technologies

to
Auditorium II
Oral presentation session

Gaming and social media use

to
Auditorium III
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Trauma and substance use

to
Auditorium VII
Oral presentation session

Unravelling the nexus: understanding drug-related violence across Europe

to
Auditorium VIII
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

14:20

Findings from The Lancet Public Health Commission on Gambling: protecting the public from gambling harms

to
Auditorium I
Oral presentation session

Alcohol and other drug policies in the work setting – a perspective on European developments

to
Auditorium II
Oral presentation session

Young people and drugs

to
Auditorium III
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session

16:00

Novel psychoactive substances and latest drug trends in Asia and Pacific countries

to
Room 1.05
Oral presentation session
MENU

EUROPE POC